tTMB-P3(12.41) Reference Standard
CBP80001-3
詢 價
索取COA
產品描述
產品數據庫
| I. Background | |||||||||||||||||||||||||||||||||||
|
Tumor mutational burden (TMB) shows great promise as a biomarker for immuno-oncology (I-O) therapy response, but progress is hindered by the lack of a standardized TMB measurement by targeted NGS panels, and an absence of TMB reference materials.
計算數據下載：DC198N0160.tmb |
|||||||||||||||||||||||||||||||||||
